-
Start Preamble
AGENCY:
Food and Drug Administration, HHS.
ACTION:
Final rule.
SUMMARY:
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect a change of address for Huvepharma AD, a sponsor of approved new animal drug applications.
DATES:
This rule is effective July 6, 2011.
Start Further InfoFOR FURTHER INFORMATION CONTACT:
Steven D. Vaughn, Center for Veterinary Medicine (HFV-100), Food and Drug Administration, 7520 Standish Pl., Rockville, MD 20855, 240-276-8300, e-mail: steven.vaughn@fda.hhs.gov.
End Further Info End Preamble Start Supplemental InformationSUPPLEMENTARY INFORMATION:
Huvepharma AD, 33 James Boucher Blvd., Sophia 1407, Bulgaria, has informed FDA that it has changed its address to 5th Floor, 3A Nikolay Haitov Str., 1113 Sofia, Bulgaria. Accordingly, the Agency is amending the regulations in 21 CFR 510.600 to reflect this change.
This rule does not meet the definition of “rule” in 5 U.S.C. 804(3)(A) because it is a rule of “particular applicability.” Therefore, it is not subject to the congressional review requirements in 5 U.S.C. 801-808.
Start List of SubjectsList of Subjects in 21 CFR Part 510
- Administrative practice and procedure
- Animal drugs
- Labeling
- Reporting and recordkeeping requirements
Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR part 510 is amended as follows:
Start PartPART 510—NEW ANIMAL DRUGS
End Part Start Amendment Part1. The authority citation for 21 CFR part 510 continues to read as follows:
End Amendment Part Start Amendment Part2. In § 510.600, in the table in paragraph (c)(1), revise the entry for “Huvepharma AD”; and in the table in paragraph (c)(2), revise the entry for “016592” to read as follows:
End Amendment PartNames, addresses, and drug labeler codes of sponsors of approved applications.* * * * *(c) * * *
(1) * * *
Firm name and address Drug labeler code * * * * * Huvepharma AD, 5th Floor, 3A Nikolay Haitov Str., 1113 Sofia, Bulgaria 016592 * * * * * (2) * * *
Drug labeler code Firm name and address * * * * * 016592 Huvepharma AD, 5th Floor, 3A Nikolay Haitov Str., 1113 Sofia, Bulgaria. * * * * * Dated: June 24, 2011.
Elizabeth Rettie,
Deputy Director, Office of New Animal Drug Evaluation, Center for Veterinary Medicine.
[FR Doc. 2011-16845 Filed 7-5-11; 8:45 am]
BILLING CODE 4160-01-P
Document Information
- Comments Received:
- 0 Comments
- Effective Date:
- 7/6/2011
- Published:
- 07/06/2011
- Department:
- Food and Drug Administration
- Entry Type:
- Rule
- Action:
- Final rule.
- Document Number:
- 2011-16845
- Dates:
- This rule is effective July 6, 2011.
- Pages:
- 39278-39278 (1 pages)
- Docket Numbers:
- Docket No. FDA-2011-N-0003
- Topics:
- Administrative practice and procedure, Animal drugs, Labeling, Reporting and recordkeeping requirements
- PDF File:
- 2011-16845.pdf
- Supporting Documents:
- » Freedom of Information Summary NADA 141-324 Phenylpropanolamine
- » Freedom of Information Summary NADA 141-331 Pergolide
- » Freedom of Information Summary NADA 141-333 - Milbemycin Oxime, Lufenuron, and Praziquantel
- » Freedom of Information Summary NADA 095-735 - Monensin
- » Freedom of Information Summary NADA 141-207 - Danofloxacin
- » Freedom of Information Summary NADA 141-322 - Gonadotropin Releasing Factor Analog-Diphtheria Toxoid Conjugate
- » Freedom of Information Summary ANDA 200-494 - Gentamicin Sulfate
- » reedom of Information Summary NADA 141-203 Deracoxib
- » Gentamicin Topical Spray (gentamicin sulfate, betamethasone valerate- ANADA 200-416; Freedom of Information Summary
- » Freedom of Information Summary ANDA 200-318 Bimectin Pour-On (Ivermectin)
- CFR: (1)
- 21 CFR 510.600